Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in Chile Marcos Cruces Olivar; Allan D. Burboa; Yolanda M. Gómez;

Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry José Rosas; José Miguel Senabre-Gallego; Gregorio Santos-Soler; José Antonio Bernal; Ana Pons Bas;

Clinical management and discontinuation of treatment in patients with recent onset rheumatoid arthritis in a rheumatology consultation Zulema Rosales Rosado; Judit Font Urgelles; Isabel Hernández Rodríguez; Leticia León Mateos; Lydia Abásolo Alcázar; Juan Ángel Jover Jover;